Amrutanjan Health Care Ltd (AMRUTANJAN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 149140, "name": "Amrutanjan Healt", "stock_name": "Amrutanjan Healt", "full_name": "Amrutanjan Health Care Ltd", "name_url": "stocks-analysis/amrutanjan-healt", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "545.45", "chg": -0.45, "chgp": "-0.08%", "dir": -1, "prev_price": "545.90", "mcapval": "1,576.00 Cr", "mcap": "Small Cap", "scripcode": 590006, "symbol": "AMRUTANJAN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE098F01031", "curr_date": "Jun 19, 03:30 PM", "curr_time": "00:57 AM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "1.03 lacs", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amrutanjan-healt-149140-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Amrutanjan Health Care Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/amrutanjan-health-care-ltd-is-rated-hold-4065191", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmrutanjanHealt_mojoScore_4065191.png", "date": "2026-06-20 10:10:03", "description": "Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amrutanjan Health Care Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/amrutanjan-health-care-ltd-faces-bearish-momentum-amid-technical-downgrade-4057958", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmrutanjanHealt_technicaldot_4057958.png", "date": "2026-06-17 08:00:29", "description": "Amrutanjan Health Care Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent performance, combined with mixed signals from MACD, RSI, and moving averages, suggests increased caution for investors amid a challenging market backdrop." }, { "title": "Amrutanjan Health Care Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/amrutanjan-health-care-ltd-is-rated-hold-4041071", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AmrutanjanHealt_mojoScore_4041071.png", "date": "2026-06-09 10:10:03", "description": "Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amrutanjan Health Care Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/amrutanjan-health-care-ltd-is-rated-hold-4018068", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmrutanjanHealt_mojoScore_4018068.png", "date": "2026-05-28 10:10:04", "description": "Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amrutanjan Health Care Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/amrutanjan-health-care-ltd-is-rated-hold-3995445", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmrutanjanHealt_mojoScore_3995445.png", "date": "2026-05-17 10:10:03", "description": "Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amrutanjan Health Care Ltd Falls 4.89%: 3 Key Factors Behind the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/amrutanjan-health-care-ltd-falls-489-3-key-factors-behind-the-weekly-decline-3984301", "imagepath": "", "date": "2026-05-10 16:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 4:</strong> Week opens at Rs.577.00</p>\n <p><strong>May 5:</strong> Intraday low hit amid price pressure (Rs.532)</p>\n <p><strong>May 6:</strong> Technical downgrade signals bearish momentum</p>\n <p><strong>May 7:</strong> Mild bullish momentum emerges with 2.74% gain</p>\n <p><strong>May 8:</strong> Week closes at Rs.548.80 (-4.89%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.577.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close<..." }, { "title": "Are Amrutanjan Health Care Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-amrutanjan-health-care-ltd-latest-results-good-or-bad-3983756", "imagepath": "", "date": "2026-05-09 19:15:36", "description": "Amrutanjan Health Care Ltd's latest financial results for Q4 FY26 highlight a narrative of strong revenue growth alongside notable pressures on profitability. The company reported net sales of ₹149.77 crores, achieving a year-on-year growth of 10.60% compared to ₹135.41 crores in the same quarter last year. This marks the highest quarterly revenue in the company's history, reflecting sustained demand for its pain relief products and an expanding product portfolio.\n\nHowever, the operational metrics present a more complex picture. The net profit for the quarter stood at ₹16.19 crores, which represents a year-on-year growth of 6.65%, down from 11.13% in the previous year. This decline in profit growth indicates challenges in maintaining profitability despite revenue expansion. The operating margin, excluding other income, was reported at 17.06%, which shows a significant year-on-year improvement of 399 basis p..." }, { "title": "Amrutanjan Health Care Q4 FY26: Strong Revenue Growth Masks Margin Pressures", "link": "https://www.marketsmojo.com/news/result-analysis/amrutanjan-health-care-q4-fy26-strong-revenue-growth-masks-margin-pressures-3983137", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmrutanjanHealt_quaterlyResult_3983137.png", "date": "2026-05-09 10:01:37", "description": "Amrutanjan Health Care Ltd., the Chennai-based pain relief and wellness products manufacturer, delivered a mixed performance in Q4 FY26 (Mar'26), with net profit rising to ₹16.19 crores—a sequential increase of 6.67% from Q3 FY26 but a modest year-on-year growth of 6.65% from ₹15.18 crores in Mar'25. The company's market capitalisation stands at ₹1,598 crores, with shares trading at ₹548.80 as of May 08, 2026, down 1.75% on the day and 17.86% year-to-date." }, { "title": "Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/amrutanjan-health-care-ltd-technical-momentum-shifts-amid-mixed-market-signals-3978612", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmrutanjanHealt_technicaldot_3978612.png", "date": "2026-05-07 08:00:26", "description": "Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a 2.74% gain on 7 May 2026, the stock’s momentum indicators and moving averages suggest a cautious outlook for investors navigating this small-cap pharmaceutical player’s evolving trend." } ], "total": 532, "sid": "149140", "stock_news_url": "https://www.marketsmojo.com/news/amrutanjan-health-care-149140" }, "announcements": [ { "details": "Amrutanjan Health Care Limited has informed the Exchange regarding Investor Presentation for the quarter ended 30.09.2019", "source": "NSE", "caption": "Amrutanjan Health Care Limited - Investor Presentation", "datetime": "08-Nov-2019" }, { "details": "Amrutanjan Health Care Limited has informed the Exchange regarding 'Statement of shares dematerialised /rematerialised during october 2019'.", "source": "NSE", "caption": "Amrutanjan Health Care Limited - Updates", "datetime": "01-Nov-2019" }, { "details": "Amrutanjan Health Care Limited has informed the Exchange regarding 'Submission of Newspaper Advertisement", "source": "NSE", "caption": "Amrutanjan Health Care Limited - Updates", "datetime": "29-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Amrutanjan Health Care Ltd has declared <strong>100%</strong> dividend, ex-date: 06 Feb 26", "dt": "2026-02-06", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Amrutanjan Health Care Ltd has announced <strong>1:2</strong> stock split, ex-date: 13 Apr 18", "dt": "2018-04-13", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 4: Week opens at Rs.577.00

May 5: Intraday low hit amid price pressure (Rs.532)

May 6: Technical downgrade signals bearish momentum

May 7: Mild bullish momentum emerges with 2.74% gain

May 8: Week closes at Rs.548.80 (-4.89%)

Week Open

Rs.577.00

Week Close<...

Read full news article

Are Amrutanjan Health Care Ltd latest results good or bad?

2026-05-09 19:15:36

Amrutanjan Health Care Ltd's latest financial results for Q4 FY26 highlight a narrative of strong revenue growth alongside notable pressures on profitability. The company reported net sales of ₹149.77 crores, achieving a year-on-year growth of 10.60% compared to ₹135.41 crores in the same quarter last year. This marks the highest quarterly revenue in the company's history, reflecting sustained demand for its pain relief products and an expanding product portfolio. However, the operational metrics present a more complex picture. The net profit for the quarter stood at ₹16.19 crores, which represents a year-on-year growth of 6.65%, down from 11.13% in the previous year. This decline in profit growth indicates challenges in maintaining profitability despite revenue expansion. The operating margin, excluding other income, was reported at 17.06%, which shows a significant year-on-year improvement of 399 basis p...

Read full news article

Amrutanjan Health Care Q4 FY26: Strong Revenue Growth Masks Margin Pressures

2026-05-09 10:01:37

Amrutanjan Health Care Ltd., the Chennai-based pain relief and wellness products manufacturer, delivered a mixed performance in Q4 FY26 (Mar'26), with net profit rising to ₹16.19 crores—a sequential increase of 6.67% from Q3 FY26 but a modest year-on-year growth of 6.65% from ₹15.18 crores in Mar'25. The company's market capitalisation stands at ₹1,598 crores, with shares trading at ₹548.80 as of May 08, 2026, down 1.75% on the day and 17.86% year-to-date.

Read full news article

Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-07 08:00:26

Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a 2.74% gain on 7 May 2026, the stock’s momentum indicators and moving averages suggest a cautious outlook for investors navigating this small-cap pharmaceutical player’s evolving trend.

Read full news article